NASDAQ: RADX
Radiopharm Theranostics Ltd Stock Ownership - Who owns Radiopharm Theranostics?

Insider buying vs selling

Have Radiopharm Theranostics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RADX insiders and whales buy or sell their stock.

RADX Shareholders

What type of owners hold Radiopharm Theranostics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Silverarc Capital Management LLC0.01%187,406$805.85kInstitution
Affinity Asset Advisors LLC0.01%156,171$671.54kInstitution
Regal Partners Ltd0.00%90,909$390.91kInstitution
Ubs Group Ag0.00%1,317$5.66kInstitution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

RADX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RADX0.02%0.00%
MLEC0.18%8.62%
VYNE21.30%78.70%Net SellingNet Selling
CLGN11.12%0.00%
GBIO63.57%36.43%Net BuyingNet Selling

Radiopharm Theranostics Stock Ownership FAQ

Who owns Radiopharm Theranostics?

Radiopharm Theranostics (NASDAQ: RADX) is owned by 0.02% institutional shareholders, 0.00% Radiopharm Theranostics insiders, and 99.98% retail investors. Silverarc Capital Management LLC is the largest individual Radiopharm Theranostics shareholder, owning 187,406.00 shares representing 0.01% of the company. Silverarc Capital Management LLC's Radiopharm Theranostics shares are currently valued at $787.11k.

If you're new to stock investing, here's how to buy Radiopharm Theranostics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.